Company Profiles

driven by the PitchBook Platform

Ability Pharmaceuticals

Ability Pharmaceuticals
2009 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$1.61M LATEST DEAL AMOUNT
$10.1M TOTAL AMOUNT RAISED
Description

Operator of a biopharmaceutical company intended to investigate cancer drugs inducing autophagy through the over expression of TRIB3 and the inhibiton of the PI3K/Akt/mTOR pathway. The company's biopharmaceutical process focuses on developing first-in-class causing autophagy molecules by the overexpression of Tribbles pseudokinase 3 (TRIB3), enabling doctors to treat multiple aggressive cancers.

Formerly Known As
AB-Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
Avenue Technology Park, 3 Center for New Technologies Business
Technology Park Vallès, Cerdanyola
08290 Barcelona
Spain

+34 93 586 8977
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ability Pharmaceuticals’s full profile, request a free trial.

Ability Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 06-Feb-2013 $1.61M $10.1M Completed Profitable
4. Early Stage VC 01-Jan-2013 00.000 000.00 Completed Profitable
3. Early Stage VC 19-Sep-2012 00.000 00.000 Completed Profitable
2. Early Stage VC 01-Jan-2010 $1.71M $2.19M Completed Profitable
1. Seed Round 01-Jan-2009 $481k $481k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Ability Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Government of Spain Government 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
Inveready Technology Investment Group Venture Capital Minority 000 0000 000000 0

You’re viewing 3 of 3 investors.

Ability Pharmaceuticals Executive Team (6)

Name Title Board
Seat
Contact
Info
Jordi Espadaler Ph.D Co-Founder & Senior Advisor
Carles Domènech Ph.D Co-Founder, Chief Executive Officer & Board Member
Marc Cortal MD Director, Clinical Research
Gemma Fierro Vice President, Clinical & Regulatory Affairs
Vanessa Ruz Vice President, Finance and Administration
You’re viewing 5 of 6 executives. Get the full list »

Ability Pharmaceuticals Board Members (7)

Name Representing Role Since Contact
Info
Carles Domènech Ph.D Ability Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
José Manuel Valadés Self Board Member 000 0000
Josep Maria Echarri Inveready Technology Investment Group Board Member 000 0000
Luis Sánchez-Lafuente Self Chairman 000 0000
Miquel Bonachera Self Vice Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »